Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 7, 2012, Pages 1859-1867

  Kobiasi, Mohammad Al ^a   Chua, Brendon Y ^b   Tonkin, David ^a   Jackson, David C ^b   Mainwaring, David E ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

chitosan; drug delivery; internalization; microparticle; nanoparticles; trafficking

Indexed keywords

CELL LINES; CELL UPTAKE; CELLULAR UPTAKE; CHITOSAN MICROPARTICLES; CHITOSAN PARTICLES; CONTROL OF SIZE; DISPERSITY; DISTRIBUTION PARAMETERS; IN-VIVO; INTERNALIZATION; LYMPH NODE; MICRO PARTICLES; MOUSE MODELS; PRECISE CONTROL; RADII OF CURVATURE; SHAPE DISTRIBUTION; SIMILAR PATTERN; SURFACTANT MOLECULES; SYSTEMATIC VARIATION; TRAFFICKING; TWO PARTICLES;

BIOMOLECULES; BODY FLUIDS; CELL CULTURE; CHITOSAN; DRUG DELIVERY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; PARTICLE SIZE; SIZE DISTRIBUTION; SURFACE ACTIVE AGENTS; TRANSPORT PROPERTIES;

NANOPARTICLES;

BIOPOLYMER; CHITOSAN; NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CELL TRANSPORT; EMULSION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PARTICLE SIZE; SHEAR RATE;

BIOPOLYMERS; CHITOSAN; EMULSIONS; FLOW CYTOMETRY; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VACCINES;

EID: 84861578472     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34153     Document Type: Article

References (36)

1. Gaumet M, Vargas A, Gurny R, Delie F,. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur J Pharma Biopharma 2008; 69: 1-9.
2. Liu ZH, Jiao YP, Wang YF, Zhou CR, Zhang ZY,. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 2008; 60: 1650-1662.
3. Sung JC, Pulliam BL, Edwards DA,. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007; 25: 563-570.
4. Tan ML, Choon PFM, Dass CR,. Cancer, chitosan nanoparticles and catalytic nucleic acids. J Pharma Pharmacol 2009; 61: 3-12.
5. Ta HT, Dunstan DE, Dass CR,. Anticancer activity and therapeutic applications of chitosan nanoparticles. CRC Press: Boca Raton; 2011. p 271-284.
6. Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IFC, Plebanski M,. Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors. J Immunol 2004; 173: 3148-3154.
7. Cohen JA, Beaudette TT, Tseng WW, Bachelder EM, Mende I, Engleman EG, Frechet JMJ,. T-Cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: The effect of particle size. Bioconjug Chem 2008; 20: 111-119.
8. Janes KA, Calvo P, Alonso MJ,. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 2001; 47: 83-97.
9. Hamidi M, Azadi A, Rafiei P,. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008; 60: 1638-1649.
10. LaVan DA, McGuire T, Langer R,. Small-scale systems for in vivo drug delivery. Nat Biotechnol 2003; 21: 1184-1191.
11. Gutman ÉM,. A statistical criterion for the degree of dispersity and allowance for the effect of particle shape on the permeability and pressibility of powders. Powder Metall Met Ceramics 1962; 1: 1-6.
12. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK,. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998; 95: 4607-4612.
13. Barry SE,. Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperthermia 2008; 24: 451-466.
14. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF,. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008; 38: 1404-1413.
15. Prabaharan M,. Review paper: Chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl 2008; 23: 5-36.
16. Prego C, Torres D, Alonso MJ,. The potential of chitosan for the oral administration of peptides. Expert Opin Drug Deliv 2005; 2: 843-854.
17. Varshosaz J,. The promise of chitosan microspheres in drug delivery systems. Expert Opin Drug Deliv 2007; 4: 263-273.
18. Carnachan RJ, Bokhari M, Przyborski SA, Cameron NR,. Tailoring the morphology of emulsion-templated porous polymers. Soft Matter 2006; 2: 608-616.
19. Grant J, Lee H, Liu RCW, Allen C,. Intermolecular interactions and morphology of aqueous polymer/surfactant mixtures containing cationic chitosan and nonionic sorbitan esters. Biomacromolecules 2008; 9: 2146-2152.
20. Sarkar J, Ramanath G, John V, Bose A,. Directed synthesis of micro-sized nanoplatelets of gold from a chemically active mixed surfactant mesophase. Interf Processes Mol Aggregat Surfact 2008; 218: 235-249.
21. Van Herk A,. Chemistry and Technology of Emulsion Polymerisation. Oxford: Blackwell; 2005. p 307.
22. Biro E, Nemeth AS, Feczko T, Toth J, Sisak C, Gyenis J,. Three-step experimental design to determine the effect of process parameters on the size of chitosan microspheres. Chem Eng Process 2009; 48: 771-779.
23. Biro E, Nemeth AS, Sisak C, Feczko T, Gyenis J,. Preparation of chitosan particles suitable for enzyme immobilization. J Biochem Biophys Methods 2008; 70: 1240-1246.
24. Dai L, Li W, Hou X,. Effect of the molecular structure of mixed nonionic surfactants on the temperature of miniemulsion formation. Colloids Surf A: Physicochem Eng Aspects 1997; 125: 27-32.
25. Warisnoicharoen W, Lansley AB, Lawrence MJ,. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharma 2000; 198: 7-27.
26. Malcolmson C, Satra C, Kantaria S, Sidhu A, Lawrence MJ,. Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. J Pharma Sci 1998; 87: 109-116.
27. Gullapalli RP, Sheth BB,. Influence of an optimized non-ionic emulsifier blend on properties of oil-in-water emulsions. Eur J Pharma Biopharma 1999; 48: 233-238.
28. Kabalnov A, Wennerstroem H,. Macroemulsion stability: The oriented wedge theory revisited. Langmuir 1996; 12: 276-292.
29. Sonneville-Aubrun O, Bergeron V, Gulik-Krzywicki T, Joensson B, Wennerstroem H, Lindner P, Cabane B,. Surfactant films in biliquid foams. Langmuir 2000; 16: 1566-1579.
30. Balinov B, Söderman O, Wärnheim T,. Determination of water droplet size in margarines and low-calorie spreads by nuclear magnetic resonance self-diffusion. J Am Oil Chem Soc 1994; 71: 513-518.
31. Rosen MJ,. Surfactants and Interfacial Phenomena, 3rd ed. New Jersey: Wiley-Interscience; 2004. p 464.
32. Wang LJ, Dong JF, Chen J, Eastoe JL, Li XF,. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 2009; 330: 443-448.
33. Myers D,. Surfaces, Interfaces, and Colloids: Principles and Applications, 2nd ed. Wiley-VCH: New York; 1999. p 501.
34. Alexandridis P, Holzwarth JF, Alan Hatton T,. Kinetics of solute partitioning at surfactant monolayers in water-in-oil microemulsions. J Mol Liquids 1997; 72: 55-68.
35. Aderem A, Underhill DM,. Mechanisms of phagocytosis in macrophages. Ann Rev Immunol 1999; 17: 593-623.
36. Conner SD, Schmid SL,. Regulated portals of entry into the cell. Nature 2003; 422: 37-44.